scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...858423L |
P356 | DOI | 10.1371/JOURNAL.PONE.0058423 |
P8608 | Fatcat ID | release_v6jtdnw4cjbwpaynhk2racekzi |
P953 | full work available at URL | http://dx.plos.org/10.1371/journal.pone.0058423 |
https://europepmc.org/articles/PMC3597721 | ||
https://europepmc.org/articles/PMC3597721?pdf=render | ||
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0058423&type=printable | ||
P3181 | OpenCitations bibliographic resource ID | 3686760 |
P932 | PMC publication ID | 3597721 |
P698 | PubMed publication ID | 23516479 |
P5875 | ResearchGate publication ID | 236068581 |
P2093 | author name string | Claude Jourdan Le Saux | |
Christopher Brampton | |||
Pooja Shivshankar | |||
Hieu Nguyen | |||
Philip Davy | |||
Richard Allsopp | |||
Calvin B. Harley | |||
Mahesh Ramaseshan | |||
Robert Tressler | |||
Steven Fauce | |||
Zhu Pirot | |||
Seema S. Ahuja | |||
P2860 | cites work | A telomerase component is defective in the human disease dyskeratosis congenita | Q22010917 |
Telomerase modulates Wnt signalling by association with target gene chromatin | Q24310084 | ||
Extension of life-span by introduction of telomerase into normal human cells | Q24336088 | ||
Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes | Q24644212 | ||
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy | Q28200083 | ||
A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis | Q29417118 | ||
Telomerase mutations in families with idiopathic pulmonary fibrosis | Q29615671 | ||
Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. | Q30374030 | ||
Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis | Q30435304 | ||
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations | Q33587591 | ||
Caveolin-1, cellular senescence and pulmonary emphysema | Q33627898 | ||
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia | Q34409487 | ||
Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia | Q35214180 | ||
Adult familial cryptogenic fibrosing alveolitis in the United Kingdom | Q35533607 | ||
Adult-onset pulmonary fibrosis caused by mutations in telomerase | Q35759839 | ||
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. | Q36138013 | ||
Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells | Q36369240 | ||
The prognosis of cryptogenic fibrosing alveolitis | Q36442446 | ||
Proteome alteration induced by hTERT transfection of human fibroblast cells | Q36661483 | ||
Telomere loss: mitotic clock or genetic time bomb? | Q36706939 | ||
Short telomeres are a risk factor for idiopathic pulmonary fibrosis | Q36861819 | ||
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | Q36970923 | ||
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? | Q36989280 | ||
Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice | Q37086294 | ||
Telomerase regulation of myofibroblast differentiation. | Q37101140 | ||
Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit | Q37219208 | ||
Apoptosis in lung injury and fibrosis. | Q37337820 | ||
Telomerase regulation during entry into the cell cycle in normal human T cells | Q37382464 | ||
Determinants of initiation and progression of idiopathic pulmonary fibrosis | Q37594222 | ||
Imetelstat (GRN163L)--telomerase-based cancer therapy | Q37674245 | ||
The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. | Q39120582 | ||
Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements | Q40208065 | ||
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. | Q41332821 | ||
Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow | Q42528725 | ||
Characterization of a new human diploid cell strain, IMR-90. | Q42802708 | ||
Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo | Q43221614 | ||
Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. | Q46515337 | ||
Alterations in lung mechanics in decorin-deficient mice | Q47921792 | ||
The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability | Q56508014 | ||
Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis | Q61942161 | ||
Regulation of telomerase activity in rat lung fibroblasts | Q77995639 | ||
Idiopathic pulmonary fibrosis--new insights | Q80057782 | ||
Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis | Q80340958 | ||
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation | Q81583972 | ||
Idiopathic pulmonary fibrosis: a disorder of lung regeneration? | Q81974285 | ||
P275 | copyright license | Creative Commons CC0 License | Q6938433 |
P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pulmonary fibrosis | Q32446 |
idiopathy | Q594841 | ||
idiopathic pulmonary fibrosis | Q2290446 | ||
murine model | Q122890741 | ||
P304 | page(s) | e58423 | |
P577 | publication date | 2013-01-01 | |
2013-03-14 | |||
P1433 | published in | PLOS One | Q564954 |
P1476 | title | A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis | |
A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary Fibrosis | |||
P478 | volume | 8 |
Q37526382 | A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study |
Q92546179 | A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length Regulation |
Q38169628 | Current concepts in the pathophysiology and treatment of aplastic anemia |
Q89578161 | Cycloastragenol as an Exogenous Enhancer of Chondrogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. A Morphological Study |
Q64993548 | Cycloastragenol: An exciting novel candidate for age-associated diseases. |
Q47988448 | Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis |
Q58579018 | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
Q34990749 | Medical school hotline: The Institute for Biogenesis Research: a flower in the Pacific |
Q38659532 | Novel strategies for anti-aging drug discovery |
Q35624348 | Overexpression of Telomerase Protects Human and Murine Lung Epithelial Cells from Fas- and Bleomycin-Induced Apoptosis via FLIP Upregulation |
Q34677829 | Pharmacokinetics, metabolism, and excretion of cycloastragenol, a potent telomerase activator in rats |
Q36885316 | Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs |
Q46113966 | TGF-β1 Signaling and Tissue Fibrosis |
Q92701873 | Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis |
Q93082066 | The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications |
Q28077460 | The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? |
Q40279088 | The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia |
Q47524535 | Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres. |
Q93086370 | Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts |
Q37514002 | Up-regulating telomerase and tumor suppressors: focusing on anti-aging interventions at the population level |
Search more.